Partners often notice reduced snoring and breathing pauses, leading to better sleep quality for both the patient and their sleep environment
Individuals with type 2 diabetes were excluded from this particular trial, meaning the results reflect outcomes in adults with obesity or overweight but without diabetes
Medical decisions Willow does not make eligibility determinations, approve prescriptions, or decide whether treatment continues
When speaking to your GP or specialist, consider raising the following: Your weight management goals and what evidence-based options are available Any supplements or compounds you are currently using or considering Symptoms you may already be experiencing that could indicate metabolic or hormonal imbalance Your eligibility for NHS-funded obesity treatments , including approved GLP-1 therapies Healthcare professionals are not there to judge but to help you make informed, safe decisions
Even if your insurance plan won't help you out, this makes GLP-1 access more accessible and affordable to many people across the nation
If experiencing symptoms such as sweating, tremor, palpitations, confusion, or dizziness, patients should check their blood glucose as these may indicate hypoglycaemia, particularly in those taking concomitant insulin or sulphonylureas
